Efficacité du Linézolide dans les bactériémies à Staphylococcus aureus résistants à la Méticilline : comparaison avec la Vancomycine et la Daptomycine
Year: 2024
Type: dissertation
Study design: Observational Study
Abstract: Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is a serious and relatively common infection. To date, Linezolid is not recommended for this indication. However, it is an interesting antibiotic with a specific spectrum of activity, optimal oral bioavailability, and low toxicity in short-term treatment. Therefore, we studied its efficacy in uncomplicated MRSA bacteremia compared to Vancomycin and Daptomycin. Materials and Methods: This is a single-center retrospective study conducted at CHU Amiens-Picardie, including all adult patients presenting with uncomplicated MRSA bacteremia treated with Linezolid, Vancomycin, or Daptomycin between 2011 and 2024. Patients were matched based on severity, age, and year of treatment. Results: Thirty- and ninety-day survival analysis did not significantly differ when compared to Vancomycin or Daptomycin. No significant differences were observed in terms of hospitalization duration, duration of bacteremia, or duration of fever. Conclusion: There was no evidence of reduced survival in the treatment of uncomplicated MRSA bacteremia with Linezolid compared to Vancomycin and Daptomycin.
Source: HAL
Author: Froment, Antoine
Institution: Université de Picardie Jules Verne
Language: French
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7163785411
